These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29196523)

  • 41. A progeroid syndrome in mice is caused by defects in A-type lamins.
    Mounkes LC; Kozlov S; Hernandez L; Sullivan T; Stewart CL
    Nature; 2003 May; 423(6937):298-301. PubMed ID: 12748643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions.
    Ramírez CL; Cadiñanos J; Varela I; Freije JM; López-Otín C
    Cell Mol Life Sci; 2007 Jan; 64(2):155-70. PubMed ID: 17131053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
    Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
    Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
    Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysregulated interactions between lamin A and SUN1 induce abnormalities in the nuclear envelope and endoplasmic reticulum in progeric laminopathies.
    Chen ZJ; Wang WP; Chen YC; Wang JY; Lin WH; Tai LA; Liou GG; Yang CS; Chi YH
    J Cell Sci; 2014 Apr; 127(Pt 8):1792-804. PubMed ID: 24522183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Senescence, regulators of alternative splicing and effects of trametinib treatment in progeroid syndromes.
    Bramwell LR; Harries LW
    Geroscience; 2024 Apr; 46(2):1861-1879. PubMed ID: 37751047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stem cell depletion in Hutchinson-Gilford progeria syndrome.
    Rosengardten Y; McKenna T; Grochová D; Eriksson M
    Aging Cell; 2011 Dec; 10(6):1011-20. PubMed ID: 21902803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations.
    Rivera-Torres J; Calvo CJ; Llach A; Guzmán-Martínez G; Caballero R; González-Gómez C; Jiménez-Borreguero LJ; Guadix JA; Osorio FG; López-Otín C; Herraiz-Martínez A; Cabello N; Vallmitjana A; Benítez R; Gordon LB; Jalife J; Pérez-Pomares JM; Tamargo J; Delpón E; Hove-Madsen L; Filgueiras-Rama D; Andrés V
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7250-E7259. PubMed ID: 27799555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature.
    Mazereeuw-Hautier J; Wilson LC; Mohammed S; Smallwood D; Shackleton S; Atherton DJ; Harper JI
    Br J Dermatol; 2007 Jun; 156(6):1308-14. PubMed ID: 17459035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells.
    Aliper AM; Csoka AB; Buzdin A; Jetka T; Roumiantsev S; Moskalev A; Zhavoronkov A
    Aging (Albany NY); 2015 Jan; 7(1):26-37. PubMed ID: 25587796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered nuclear functions in progeroid syndromes: a paradigm for aging research.
    Li B; Jog S; Candelario J; Reddy S; Comai L
    ScientificWorldJournal; 2009 Dec; 9():1449-62. PubMed ID: 20024518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis.
    Bridger JM; Kill IR
    Exp Gerontol; 2004 May; 39(5):717-24. PubMed ID: 15130666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced SRSF5 Protein Expression Reinforces Lamin A mRNA Production in HeLa Cells and Fibroblasts of Progeria Patients.
    Vautrot V; Aigueperse C; Oillo-Blanloeil F; Hupont S; Stevenin J; Branlant C; Behm-Ansmant I
    Hum Mutat; 2016 Mar; 37(3):280-91. PubMed ID: 26670336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis.
    Csoka AB; English SB; Simkevich CP; Ginzinger DG; Butte AJ; Schatten GP; Rothman FG; Sedivy JM
    Aging Cell; 2004 Aug; 3(4):235-43. PubMed ID: 15268757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.
    Scaffidi P; Misteli T
    Nat Med; 2005 Apr; 11(4):440-5. PubMed ID: 15750600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
    Bifulco M; D'Alessandro A; Paladino S; Malfitano AM; Notarnicola M; Caruso MG; Laezza C
    FEBS J; 2013 Dec; 280(23):6223-32. PubMed ID: 24112551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
    Yang SH; Bergo MO; Toth JI; Qiao X; Hu Y; Sandoval S; Meta M; Bendale P; Gelb MH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10291-6. PubMed ID: 16014412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
    Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
    Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene expression and DNA repair in progeroid syndromes and human aging.
    Kyng KJ; Bohr VA
    Ageing Res Rev; 2005 Nov; 4(4):579-602. PubMed ID: 16246641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tethering by lamin A stabilizes and targets the ING1 tumour suppressor.
    Han X; Feng X; Rattner JB; Smith H; Bose P; Suzuki K; Soliman MA; Scott MS; Burke BE; Riabowol K
    Nat Cell Biol; 2008 Nov; 10(11):1333-40. PubMed ID: 18836436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.